Keywords: arqule, bayer, sign, million, deal, entered, into

ArQule and Bayer sign $30 million deal

Article | 11 October 1999

ArQule has entered into a three-year collaboration with Bayer "to designand create several hundred thousand compounds for screening" against the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Go to company listing

Related Drugs

Aspirin

Bayer

Go to drug listing